Is there a common genetic link for depression and cardiovascular disease?

December 09, 2002

A large body of evidence has emerged over several years for an association between depressive disorder and cardiovascular disease. Although many studies have shown that depression increases the risk for coronary artery disease and the mortality rates after myocardial infarction, there is recent support for the assumption that the relation between both disorders may be bi-directional. The mechanisms of this interaction are at present uncertain and several factors, including stress with its multiple actions on brain and peripheral organs, acute inflammatory reactions with altered immune function as well as a genetically driven susceptibility to develop the disorders are under debate.

Regarding the genetic contribution, variants in two genes were repeatedly discussed as important predisposing factor for cardiovascular function and disease. The gene coding for the angiotensin-converting-enzyme (ACE), an enzyme which is involved in the development of hypertension and other cardiovascular distress, has a common mutation (allele-D) which results in increased ACE concentration (consequently, ACE inhibitors are used as antihypertensive agents). Several studies have shown an association between this allele-D and cardiovascular disorders, supporting the hypothesis of a genetic contribution. However, not only the actual concentration of ACE but also other factors are relevant for cardiovascular function and the development of diseases. Among those is the transduction of nervous signals, which is regulated by various components, including G-proteins. G-proteins are located within the cellular membranes and are thus key elements for the signal transduction, as they induce a cascade of cell reactions after the incoming signal. Thus alterations in the function of these G-proteins could have tremendous effects upon rapidity and quality of the nervous signal transmission. And recently a mutation in one subtype of these G-protein genes, the G-ß3 subunit allele-T was observed not only in obesity but also in patients with hypertension. Moreover, the combination of these two variants of the ACE and G-ß3 genes have recently been shown to increase the risk for myocardial infarction. Interestingly, both proteins and their genes are not only relevant in periphery for cardiovascular disorders, but have also impact on many aspects of brain function and for the development of psychiatric disorders, including depression. Thus, in a previous investigation study the authors had shown, that the G-ß3-T allele was more frequent among depressive patients, although they were not hypertensive.

The aim of the present study was to figure out whether a combination of both gene variants might be important also in depression and could thus be a link between both disorders. Researchers in Germany have carried out a combined analysis of the allelic variants of the ACE and G-ß3 genes in a cohort of 201 patients with severe depression and 161 healthy controls. Their data revealed an increased frequency of the combined ACE-D and the G-ß3-T alleles in depressive patients, as 17% of the depressed patients, but only 3% of the controls, had the same allelic combination of those two genes, that were previously shown to increase the risk for myocardial infarction. As these combined alleles are present only in a subset of patients, one might argue that this combination represents a special group of depression, maybe one of older patients with already obvious cardiovascular disturbances. However, this was not the case, as this patient group did not distinguish concerning age, cardiovascular morbidity, depressive symptomatology or other risk factors, such as smoking, cholesterol, blood lipids or the body mass index. Although the authors are presently unable to predict whether this group of patients will develop severe cardiovascular disease or is at increased risk for myocardial infarction, their data do suggest that the increased rates of cardiovascular disease in patients with major depression may at least partly be the result of a gene-gene interaction which is thus predisposing to depression, cardiovascular disease or to both.
-end-
Citation source: Molecular Psychiatry 2002 Volume 7, number 10, pages 1120-1126.

Article: Combined action of the ACE D- and G-protein ß3 T-allele in major depression: a possible link to cardiovascular disease?

Authors; Brigitta Bondy, Thomas C. Baghai, Petr Zill, Ronald Bottlender, Markus Jaeger, Cornelius Schuele, Peter Zwanzger, Rainer Rupprecht, Rolf R. Engel

Psychiatry Department, Munich University, Munich, Germany

For further information on this work, please contact Prof. Dr. Brigitta Bondy, Psychiatric Hospital of University Munich, Nussbaumstraße 7, D-80336 Munich, Germany; Phone. 49-89-5160-2737; Fax: 0049-89-5160-4741; e-mail: Brigitta.Bondy@psy.med.uni-muenchen.de

Molecular Psychiatry is published by the Nature Publishing Group. http://www.nature.com/mp

Editor: Julio Licinio, M.D.; phone: 310-825-7113; FAX: 310-206-6715; e-mail: licinio@ucla.edu

For a copy of this article and accompanying editorial, please contact Aimee Midei, editorial assistant, e-mail: molecularpsychiatry@mednet.ucla.edu.

PLEASE CITE MOLECULAR PSYCHIATRY AS THE SOURCE OF THIS MATERIAL.

Molecular Psychiatry

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.